Group One Trading, L.P. Kura Oncology, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.42 - $23.53 $25,390 - $44,518	1,892 Added 812.02%	2,125 $45,000
Q4 2023 Feb 14, 2024	BUY	$7.58 - $14.38 $1,766 - $3,350	233 New	233 $3,000
Q2 2023 Aug 09, 2023	BUY	$9.62 - $13.99 $74,506 - $108,352	7,745 New	7,745 $81,000
Q2 2022 Aug 11, 2022	SELL	$10.71 - $18.33 $67,430 - $115,405	-6,296 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$11.78 - $16.98 $74,166 - $106,906	6,296 New	6,296 $101,000
Q4 2021 Feb 11, 2022	SELL	$12.22 - $19.57 $39,873 - $63,856	-3,263 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $9,051 - $12,749	587 Added 21.94%	3,263 $61,000
Q1 2021 May 12, 2021	SELL	$24.75 - $39.14 $202,430 - $320,126	-8,179 Reduced 75.35%	2,676 $76,000
Q4 2020 Feb 10, 2021	BUY	$29.0 - $41.62 $287,883 - $413,161	9,927 Added 1069.72%	10,855 $355,000
Q3 2020 Nov 12, 2020	SELL	$16.3 - $30.64 $35,256 - $66,274	-2,163 Reduced 69.98%	928 $28,000
Q2 2020 Aug 13, 2020	BUY	$7.95 - $18.81 $10,303 - $24,377	1,296 Added 72.2%	3,091 $50,000
Q1 2020 May 13, 2020	SELL	$6.45 - $14.04 $4,882 - $10,628	-757 Reduced 29.66%	1,795 $18,000
Q4 2019 Feb 10, 2020	BUY	$12.97 - $15.94 $33,099 - $40,678	2,552 New	2,552 $35,000
Q1 2019 May 13, 2019	SELL	$13.73 - $16.87 $10,448 - $12,838	-761 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$10.6 - $17.49 $42 - $69	4 Added 0.53%	761 $11,000
Q3 2018 Nov 08, 2018	BUY	$16.65 - $21.85 $2,497 - $3,277	150 Added 24.71%	757 $13,000
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $799 - $1,015	54 Added 9.76%	607 $11,000
Q1 2018 May 11, 2018	BUY	$14.5 - $23.4 $8,018 - $12,940	553 New	553 $10,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$68.4 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.3 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$51.9 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.4 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$38.7 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account